quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:23:23·49d
INSIDERFiling
National Health Investors Inc. logo

Director Colden Tracy M J was granted 1,268 shares, increasing direct ownership by 11% to 12,858 units (SEC Form 4)

NHI· National Health Investors Inc.
Real Estate
Original source

Companies

  • NHI
    National Health Investors Inc.
    Real Estate

Recent analyst ratings

  • Jan 20UpdateDeutsche Bank$85.00
  • Oct 1UpdateCantor Fitzgerald$90.00
  • Jul 10UpdateKeyBanc Capital Markets-
  • Jul 2UpdateTruist$77.00
  • Oct 1UpdateWells Fargo$86.00
  • Sep 24UpdateBofA Securities$92.00

Related

  • SEC9h
    National Health Investors Inc. filed SEC Form 8-K: Leadership Update
  • PR9h
    NHI Announces CFO Succession Plan; John Spaid to Retire, Todd Siefert Named Successor
  • PR1d
    Blueprint acts as transaction advisor to National Health Investors, Inc. (NYSE: NHI) in its planned $560 million disposition of a 35-property healthcare portfolio to National HealthCare Corporation (NYSE American: NHC).
  • SEC1d
    Amendment: National Health Investors Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
  • SEC2d
    National Health Investors Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
  • NEWS2d
    NHI Announces Sale of NHC Portfolio for $560 Million
  • NEWS7d
    NHI Announces First Quarter 2026 Earnings Release and Conference Call Dates
  • SEC20d
    SEC Form DEFA14A filed by National Health Investors Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022